Therapeutic Implications for Immunophilin Ligands in the Treatment of Neurodegenerative Diseases

E-ISSN： 2212-5299|2|6|349-356

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.2, Iss.6, 2003-12, pp. : 349-356

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Free Radicals in the Neurodegenerative Diseases: Therapeutic Implications for Antioxidant Treatment

By Halliwell B.

Drugs & Aging, Vol. 18, Iss. 9, 2001-01 ,pp. : 685-716

Adis International

Access to resources Recommend Favorite

AMPK in Neurodegenerative Diseases: Implications and Therapeutic Perspectives

Current Drug Targets, Vol. 17, Iss. 8, 2016-06 ,pp. : 890-907

Bentham Science Publishers

Access to resources Recommend Favorite

Aggresome Formation and Neurodegenerative Diseases: Therapeutic Implications

Current Medicinal Chemistry, Vol. 15, Iss. 1, 2008-01 ,pp. : 47-60

Bentham Science Publishers

Access to resources Recommend Favorite

Immunophilin ligands for the treatment of neurological disorders

By Hamilton G.S.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 9, 1998-09 ,pp. : 1109-1124

Informa Healthcare

Access to resources Recommend Favorite

Inflammation in Parkinson's Diseases and Other Neurodegenerative Diseases: Cause and Therapeutic Implications

Current Pharmaceutical Design, Vol. 13, Iss. 18, 2007-06 ,pp. : 1925-1928

Bentham Science Publishers

Access to resources Recommend Favorite